Contraceptive Use and Associated Factors among Women Enrolling into HIV Care in Southwestern Uganda
Table 1
Demographic and behavioral characteristics among non-pregnant, sexually active women enrolling at ISS Clinic, Mbarara Uganda, during 2009.
Total (col%)
All
826 (100.0)
Demographics
Age (years) (median (IQR))
29 (24–35)
18–24
211 (25.5)
25–29
206 (25.0)
30–35
234 (28.3)
36–39
175 (21.2)
Education
None
0 (0.0)
Primary level
453 (54.8)
Secondary
148 (17.9)
Tertiary
64 (7.8)
Missing
161 (19.5)
Marital status
Married
398 (48.5)
Previously married (separated, divorced, or widowed)
348 (42.4)
Not married
75 (9.1)
Tribe
Kiga
81 (9.8)
Nkole
596 (72.2)
Other
109 (13.2)
Missing
40 (4.8)
Religion
Catholic
246 (29.8)
Protestant
419 (50.7)
Muslim
83 (10.0)
Other
22 (2.7)
Missing
56 (6.8)
Monthly income (USH)
<100,000
575 (69.7)
100,000–250,000
73 (8.8)
>250,000
16 (1.9)
Missing
162 (19.6)
Among married persons: HIV status of spouse
Negative
21 (5.3)
Positive
281 (70.6)
Unknown
70 (17.6)
Missing
26 (6.5)
Among married persons: HIV status disclosure
Disclosed to spouse
279 (70.1)
Disclosed to someone but not to spouse
48 (12.6)
No disclosure reported
71 (17.8)
Among un-married persons: HIV status disclosure
Disclosed to sexual partner
13 (3.1)
Disclosed to others but not to sexual partner
301 (71.2)
No disclosure reported
109 (25.8)
Health status
WHO clinical stage*
Stage 1 or 2
526 (63.7)
Stage 3 or 4
200 (24.2)
Missing
100 (12.1)
CD4 cell count (/mm3)
200
219 (26.5)
201–350
149 (18.0)
351–500
115 (14.0)
>500
205 (24.8)
Missing
138 (16.7)
Number of living biological children
0 children
39 (4.7)
1-2 children
208 (25.2)
3 or more children
186 (22.5)
Missing
393 (47.6)
Type of contraceptive method used
None
596 (72.2)
Condoms
68 (8.2)
Oral contraceptives
20 (2.4)
Injectable hormones
119 (14.4)
Norplant
0 (0.0)
Natural family planning/rhythm method
7 (0.9)
Intrauterine device
1 (0.1)
Sterilization
5 (0.6)
Diaphragm
2 (0.2)
Other
3 (0.4)
Condom use + another method
5 (0.6)
*WHO clinical stage refers to the World Health Organization clinical staging for HIV disease based on symptoms, signs and diagnosed opportunistic infections in clients with HIV infection. Stages 1 and 2 are considered asymptomatic or mild disease, while stages 3 and 4 are considered severe disease and patients in these categories should begin antiretroviral therapy.
